drugset / Trial / NCT04836520
SHR6390 Combined With Anastrozole for Preoperative Treatment of Breast Cancer.
Phase 2
Completed
20 enrolled
Tianjin Medical University Cancer Institute and Hospital
Jiangsu HengRui Medicine Co., Ltd. · collab
NaSingle-groupOpen-labelTreatment
Summary
The study is being conducted to assess effect of SHR6390 combined with anastrozole on proliferation of HR-positive HER2-negative breast cancer tumor cells before surgery.
Timeline
- Start
- 2021-08-02
- Primary completion
- 2023-02-28
- Completion
- 2023-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dalpiciclib | Small molecule | — | — |
| Subject | anatrozole | Unknown | — | — |